It would seem that the time when machines surpass the ability of humans to do intricate work is almost here. One of Google’s Artificial Intelligence projects is apparently capable of diagnosing the retina of patients to see if they are about to go blind. The search engine company even went so far as to claim that the AI is better than actual doctors at diagnosis.
As Google noted in a blog post about the AI, Diabetic retinopathy is a quickly rising cause of blindness among patients in the world. The disease is treatable, but only if it is caught early enough to respond to treatments. This is where effective diagnosis comes into play.
“Unfortunately, medical specialists capable of detecting the disease are not available in many parts of the world where diabetes is prevalent,” the blog post reads. “We believe that Machine Learning can help doctors identify patients in need, particularly among underserved populations.”
The findings with regards to the diagnostic capabilities of the AI was published in the Journal of the American Medical Association. The paper included proposals on certain potential benefits that machine learning could provide with regards to diagnosing medical problems and even helping to find ways to treat them.
In the case of blindness caused by Diabetic retinopathy, the AI is fed images of retinas, which it will then scan and analyze for any of the telltale sign of impending blindness. After going through 128,000 images of retinas with the traits that led to the condition, the AI was given 10,000 new images to diagnose. Based on the results, the machine was much better at detecting which images posed the biggest threat of blindness for the subjects.
There are significant advantages to having this kind of powerful tool, especially with regards to detecting and curing diseases. However, there is also the startling implication that if a machine can replace vocations as complex and important as those in the medical profession, just how much of human society can AI replace?


AI-Driven Inflation Raises U.S. Consumer Prices, Goldman Sachs Says
CDC Monitors U.S. Travelers After Hantavirus Outbreak on Luxury Cruise Ship
Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone
U.S.-China AI Talks May Take Center Stage at Trump-Xi Summit
The four types of dementia most people don’t know exist
Dell Stock Hits Record High After Trump Endorsement, AI Server Demand Fuels Rally
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
Why the future of marijuana legalization remains hazy despite high public support
TikTok Nears $400 Million Settlement With Trump Administration Over Child Privacy Lawsuit
Ibiden Stock Surges as AI Chip Demand Boosts Profit Outlook
Hantavirus Cruise Ship Outbreak Triggers Global Health Alert
Trump Reportedly Approves Plan to Remove FDA Commissioner Marty Makary Amid Growing Controversies
Supermicro Forecasts Strong Q4 Revenue Growth as AI Server Demand Surges
AWS Data Center Overheating Disrupts Cloud Services in Northern Virginia
OpenAI-Microsoft Deal Sets $38 Billion Revenue-Sharing Cap Ahead of Potential IPO
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal 



